PLANNED EXTENSION OF EU PENALTIES FOR PAEDIATRIC MEDICINE RULE BREACHES BROADLY WELCOMED
July 1st, 2011
BY KEITH NUTHALL
CONDITIONAL support has been secured for the European Commission's plans to extend the European Union (EU) pharmaceutical industry financial penalties system to the EU's paediatric regulation controlling child medicines.
In a formal comment, the European Federation of Pharmaceutical Industries and Associations (EFPIA) backed the idea, but stressed fines should only be levied on medicine manufacturers for major breaches of paediatric medicine rules: "Where the infringements concerned may have significant public health implications in the EU, ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.